Edward J. Dulac III, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 7,028 shares at $4.37 ($31K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Seasonal sale ($31k) by Chief Financial Officer — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |